{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T17:23:08Z","timestamp":1783531388409,"version":"3.55.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Adolescent and young adult overdoses and overdose fatalities continue to increase despite reductions in self-reported substance use. This review aims to explore factors contributing to this overdose epidemic, highlight signs of overdose and the role of the overdose reversal medication naloxone, and provide recommendations for practice change to support patients and decrease their risk of unintentional overdose.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>The potent opioid fentanyl is a common contaminant in nonopioid substances, as well as in heroin and counterfeit pills, heightening risk of fatal overdose. Adolescents and young adults who die of overdose are rarely engaged in substance use disorder treatment. Medications for opioid use disorder are effective at reducing risk of fatal overdose but are underutilized, as is the opioid reversal medication naloxone.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Pediatric clinician engagement in harm reduction with adolescents and young adults, starting with screening through a confidential interview, may enhance pathways to care and reduce the risk of overdose.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mop.0000000000001249","type":"journal-article","created":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T03:01:39Z","timestamp":1679972499000},"page":"408-414","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Unintentional overdoses: understanding the fentanyl landscape and reducing harm"],"prefix":"10.1097","volume":"35","author":[{"given":"Lauren A.","family":"Bell","sequence":"first","affiliation":[{"name":"Division of Adolescent Medicine and Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, Indiana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott E.","family":"Hadland","sequence":"additional","affiliation":[{"name":"Division of Adolescent and Young Adult Medicine, Massachusetts General Hospital"},{"name":"Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,3,28]]},"reference":[{"key":"R2-20250730","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1056\/NEJMc2201761","article-title":"Current causes of death in children and adolescents in the United States","volume":"386","author":"Goldstick","year":"2022","journal-title":"N Engl J Med"},{"key":"R3-20250730","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.15585\/mmwr.mm7150a2","article-title":"Drug overdose deaths among persons aged 10-19 years \u2014 United States July 2019\u2013December 2021","volume":"71","author":"Tanz","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R6-20250730","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1001\/jama.2022.2847","article-title":"Trends in drug overdose deaths among US adolescents, January 2010 to June 2021","volume":"327","author":"Friedman","year":"2022","journal-title":"JAMA"},{"key":"R7-20250730","doi-asserted-by":"crossref","first-page":"e583","DOI":"10.21106\/ijma.583","article-title":"Monthly trends in drug overdose mortality among youth aged 15-34 years in the United States, 2018-2021: measuring the impact of the COVID-19 pandemic","volume":"11","author":"Lee","year":"2022","journal-title":"Int J MCH AIDS"},{"key":"R8-20250730","doi-asserted-by":"crossref","first-page":"109309","DOI":"10.1016\/j.drugalcdep.2022.109309","article-title":"Drug overdose mortality by race\/ethnicity across US-born and immigrant populations","volume":"232","author":"Cano","year":"2022","journal-title":"Drug Alcohol Depend"},{"key":"R9-20250730","doi-asserted-by":"crossref","first-page":"38","DOI":"10.15585\/mmwr.su6901a5","article-title":"Prescription opioid misuse and use of alcohol and other substances among high school students - Youth Risk Behavior Survey United States 2019","volume":"69","author":"Jones","year":"2020","journal-title":"MMWR Suppl"},{"key":"R13-20250730","first-page":"1","article-title":"Fentanyl availability on darknet markets","volume":"590","author":"Broadhurst","year":"2020","journal-title":"Aust Inst Criminol Trends Issues Crime Crim justice"},{"key":"R15-20250730","doi-asserted-by":"crossref","first-page":"e192851","DOI":"10.1001\/jamanetworkopen.2019.2851","article-title":"Rate of fentanyl positivity among urine drug test results positive for cocaine or methamphetamine","volume":"2","author":"LaRue","year":"2019","journal-title":"JAMA Netw Open"},{"key":"R16-20250730","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/injuryprev-2020-043968","article-title":"Increasing presence of xylazine in heroin and\/or fentanyl deaths, Philadelphia, Pennsylvania, 2010\u20132019","volume":"27","author":"Johnson","year":"2021","journal-title":"Inj Prev"},{"key":"R17-20250730","first-page":"3","article-title":"Opioid overdose. Challenging cases","author":"Schiller","year":"2022","journal-title":"Complicat Manag Pain Med"},{"key":"R18-20250730","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S2215-0366(16)00002-X","article-title":"Prevention, early intervention, harm reduction, and treatment of substance use in young people","volume":"3","author":"Stockings","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"R19-20250730","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1080\/07853890.2022.2104922","article-title":"Addressing adolescent substance use with a public health prevention framework: the case for harm reduction","volume":"54","author":"Winer","year":"2022","journal-title":"Ann Med"},{"issue":"(Suppl 2)","key":"R20-20250730","doi-asserted-by":"crossref","first-page":"S240","DOI":"10.1542\/peds.2020-023523G","article-title":"Principles of harm reduction for young people who use drugs","volume":"147","author":"Kimmel","year":"2021","journal-title":"Pediatrics"},{"key":"R21-20250730","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jadohealth.2020.12.142","article-title":"Opioid use disorder stigma, discrimination, and policy attitudes in a national sample of U.S. young adults","volume":"69","author":"Adams","year":"2021","journal-title":"J Adolesc Health"},{"key":"R22-20250730","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.jadohealth.2022.11.051","article-title":"Denial and self-management: how adolescents and young adults initiate, escalate, problematize, and contemplate disclosure and treatment of opioid use","volume":"72","author":"Bell","year":"2023","journal-title":"J Adolesc Heal"},{"issue":"(2 Suppl 2)","key":"R23-20250730","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.jadohealth.2012.05.006","article-title":"Adolescent neurodevelopment","volume":"52","author":"Spear","year":"2013","journal-title":"J Adolesc Health"},{"key":"R24-20250730","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.drugpo.2007.01.003","article-title":"Merseyside, the first harm reduction conferences, and the early history of harm reduction","volume":"18","author":"O\u2019Hare","year":"2007","journal-title":"Int J Drug Policy"},{"key":"R25-20250730","first-page":"317","article-title":"Inconsistency among American states on the age at which minors can consent to substance abuse treatment","volume":"35","author":"Weisleder","year":"2007","journal-title":"J Am Acad Psychiatry Law"},{"key":"R33-20250730","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1001\/jamapediatrics.2021.4606","article-title":"Access to medications for opioid use disorder and associated factors among adolescents and young adults: a systematic review","volume":"176","author":"Pilarinos","year":"2022","journal-title":"JAMA Pediatr"},{"key":"R34-20250730","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.annemergmed.2021.10.005","article-title":"Naloxone and buprenorphine prescribing following us emergency department visits for suspected opioid overdose: August 2019 to April 2021","volume":"79","author":"Chua","year":"2022","journal-title":"Ann Emerg Med"},{"key":"R35-20250730","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/M17-3107","article-title":"Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study","volume":"169","author":"Larochelle","year":"2018","journal-title":"Ann Intern Med"},{"issue":"(2)","key":"R36-20250730","first-page":"CD002207","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","author":"Mattick","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"R37-20250730","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1542\/pir.2017-0153","article-title":"Medication treatment of adolescent opioid use disorder in primary care","volume":"39","author":"Carney","year":"2018","journal-title":"Pediatr Rev"},{"key":"R38-20250730","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jadohealth.2020.12.129","article-title":"Medication for adolescents and young adults with opioid use disorder","volume":"68","author":"Hadland","year":"2021","journal-title":"J Adolesc Heal"},{"key":"R39-20250730","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/15374416.2018.1466307","article-title":"Evidence base on outpatient behavioral treatments for adolescent substance use, 2014-2017: outcomes, treatment delivery, and promising horizons","volume":"47","author":"Hogue","year":"2018","journal-title":"J Clin Child Adolesc Psychol"},{"key":"R40-20250730","doi-asserted-by":"crossref","first-page":"e2022057529","DOI":"10.1542\/peds.2022-057529","article-title":"Recommended terminology for substance use disorders in the care of children, adolescents, young adults, and families","volume":"149","author":"Alinsky","year":"2022","journal-title":"Pediatrics"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001249","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T18:02:58Z","timestamp":1753898578000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,28]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000001249","relation":{},"ISSN":["1040-8703","1531-698X"],"issn-type":[{"value":"1040-8703","type":"print"},{"value":"1531-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,28]]}}}